<h2 id="Headline">
 Headline
</h2>
<h3 id="The_importance_of_being_disordered">
 The importance of being disordered
</h3>
<p>
 Intrinsically disordered regions are protein regions that lack a fixed or ordered three-dimensional structure, typically in the absence of interaction partners. They are thought to often drive liquid-liquid phase separation within cells. This process leads to the formation of biomolecular condensates devoid of a surrounding lipid membrane, which are responsible for extensively compartmentalizing eukaryotic cells. Liquid-liquid phase separation plays crucial roles in fundamental cellular processes, such as the stress response, among others. Indeed eukaryotic cells react to a wide range of stresses by assembling proteins and mRNAs into massive ribonucleoprotein stress granules (SGs) that regulate mRNA translation and degradation. Interestingly mRNAs modified through the methylation of adenosine (m
 <sup>
  6
 </sup>
 A) are
 <a href="https://pubmed.ncbi.nlm.nih.gov/?term=32451507">
  enriched in SGs
 </a>
 . The m
 <sup>
  6
 </sup>
 A modification is very common, with around 25% of mRNAs containing at least one m
 <sup>
  6
 </sup>
 A. It is recognized by a protein domain, called
 <a href="https://prosite.expasy.org/doc/PS50882">
  YTH
 </a>
 , which is conserved from yeast to humans. In humans and mice, there are
 <a href="http://www.uniprot.org/uniprot/?query=(gene:ythdf1+OR+gene:ythdf2+OR+gene:ythdf3)+AND+(organism:9606+OR+organism:10090)+AND+reviewed:yes">
  3 such proteins
 </a>
 , YTHDF1, YTHDF2 and YTHDF3. All 3 paralogs contain a C-terminal YTH domain and disordered regions are predicted in their N-terminal moieties. These proteins colocalize with stress granules.
</p>
<p>
 Could YTHDF proteins and their modified RNA partners be active players in the process of stress granule formation? In vitro, RNAs containing at least 4 copies of m
 <sup>
  6
 </sup>
 A motifs, but not those with a single motif,
 <a href="https://pubmed.ncbi.nlm.nih.gov/?term=31388144">
  dramatically enhance phase separation of YTHDF proteins
 </a>
 . When transfected into cells, multivalent m
 <sup>
  6
 </sup>
 A RNA oligos promote localization of YTHDF proteins to stress granules. Moreover,
 <a href="https://pubmed.ncbi.nlm.nih.gov/?term=32451507">
  depletion of YTHDF proteins inhibits SG formation and recruitment of mRNAs to SGs
 </a>
 . Both the N-terminal intrinsically disordered region and the C-terminal m
 <sup>
  6
 </sup>
 A-binding YTH domain of YTHDF proteins are required for SG formation. It has been proposed that polymethylated mRNAs may act as a
 <a href="https://pubmed.ncbi.nlm.nih.gov/?term=31292544">
  multivalent scaffold for the binding of YTHDF proteins, juxtaposing their low-complexity domains and thereby leading to phase separation
 </a>
 .
</p>
<p>
 As of this release, we have introduced predictions of long, intrinsically disordered regions into the UniProtKB annotation pipeline, using the
 <a href="https://doi.org/10.1093/bioinformatics/btx015">
  MobiDB-lite
 </a>
 method.
 <a href="http://www.uniprot.org/uniprot/?query=(gene:ythdf1+OR+gene:ythdf2+OR+gene:ythdf3)+AND+reviewed:yes">
  YTHDF entries
 </a>
 have been updated and are now publicly available.
</p>
<h2 id="UniProt_knowledge_graph_news">
 UniProt knowledge graph news
</h2>
<p>
 Using UniProt in a public cloud is now easier than ever, as UniProt is now available as part of the
 <a href="https://registry.opendata.aws/uniprot/">
  AWS open data program
 </a>
 . AWS has published a
 <a href="https://aws.amazon.com/blogs/industries/exploring-the-uniprot-protein-knowledgebase-with-aws-open-data-and-amazon-neptune/">
  tutorial on how you can use the public UniProt data in
your own private graph database
 </a>
 using
 <a href="https://aws.amazon.com/neptune/">
  AWS Neptune
 </a>
 . This shows how the
 <strong>
  I
 </strong>
 (for
 <strong>
  I
 </strong>
 nteroperability) in
 <a href="https://www.nature.com/articles/s41597-019-0180-9">
  FAIR UniProt
 </a>
 works with commercial cloud-based tools. Of course the UniProt Knowledge Graph remains freely available at
 <a href="https://sparql.uniprot.org">
  sparql.uniprot.org
 </a>
 .
</p>
<h2 id="UniProtKB_news">
 UniProtKB news
</h2>
<h3 id="Introduction_of_MobiDB_lite_predictions_for_intrinsically_disordered_regions">
 Introduction of MobiDB-lite predictions for intrinsically disordered regions
</h3>
<p>
 Starting with this release of UniProt, we import predictions of
 <a href="https://en.wikipedia.org/wiki/Intrinsically%5Fdisordered%5Fproteins">
  intrinsically disordered regions
 </a>
 and regions of compositional bias, generated with the
 <a href="https://doi.org/10.1093/bioinformatics/btx015">
  MobiDB-lite method
 </a>
 , in UniProtKB/Swiss-Prot. These computationally generated annotations are represented as
 <a href="http://www.uniprot.org/help/region">
  Region
 </a>
 and
 <a href="http://www.uniprot.org/help/compbias">
  Compositional bias
 </a>
 annotations tagged with the evidence code
 <code>
  ECO:0000256
 </code>
 (sequence model evidence used in automatic assertion) and source
 <code>
  SAM:MobiDB-lite
 </code>
 . Entries with disordered regions can be retrieved using these queries:
</p>
<p>
 <a href="http://www.uniprot.org/uniprot/?query=annotation%3A(type%3Aregion+disordered)+reviewed%3Ayes">
  annotation:(type:region disordered) AND reviewed:yes
 </a>
 <br/>
 <a href="http://www.uniprot.org/uniprot/?query=annotation%3A(type%3Acompbias)+reviewed%3Ayes">
  annotation:(type:compbias) AND reviewed:yes
 </a>
</p>
<p>
 In cases where there is experimental evidence for intrinsically disordered regions, curators can modify the predicted results, or add new expert-curated regions, using the appropriate experimental
 <a href="http://www.uniprot.org/help/evidences">
  evidence attribution
 </a>
 .
</p>
<p>
 Predictions from the MobiDB-lite method are also available for protein sequences in UniProtKB/TrEMBL - tagged with the same evidence code and source as in reviewed entries. They can be obtained by using these queries:
</p>
<p>
 <a href="http://www.uniprot.org/uniprot/?query=annotation%3A(type%3Aregion+disordered)+reviewed%3Ano">
  annotation:(type:region disordered) AND reviewed:no
 </a>
 <br/>
 <a href="http://www.uniprot.org/uniprot/?query=annotation%3A(type%3Acompbias)+reviewed%3Ano">
  annotation:(type:compbias) AND reviewed:no
 </a>
</p>
<p>
 See also:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/help/sam">
   SAM - Sequence Analysis Methods for automatic annotation
  </a>
 </li>
</ul>
<h3 id="Changes_to_the__a_href___docs_humdisease__controlled_vocabulary_of_human_diseases__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/humdisease">
  controlled vocabulary of human diseases
 </a>
</h3>
<p>
 New diseases:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06011">
   Albinism, oculocutaneous, 8
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06008">
   AMED syndrome, digenic
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06002">
   Amyotrophic lateral sclerosis 26, with or without frontotemporal dementia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06040">
   Blistering, acantholytic, of oral and laryngeal mucosa
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06003">
   Carpal tunnel syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06013">
   Chorioretinal atrophy, progressive bifocal
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06028">
   Deafness, autosomal recessive, 117
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06032">
   Deafness, congenital, and adult-onset progressive leukoencephalopathy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06025">
   Developmental and epileptic encephalopathy 90
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06005">
   Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06037">
   ENDOVE syndrome, limb-brain type
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06036">
   ENDOVE syndrome, limb-only type
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06052">
   Epilepsy, progressive myoclonic 12
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06018">
   Erythrokeratodermia variabilis et progressiva 7
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06001">
   Frontotemporal dementia and/or amyotrophic lateral sclerosis 5
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06000">
   Frontotemporal dementia and/or amyotrophic lateral sclerosis 8
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06046">
   Gastric adenocarcinoma and proximal polyposis of the stomach
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06004">
   Hermansky-Pudlak syndrome 11
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06026">
   Immunodeficiency 76
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06050">
   Intellectual developmental disorder, autosomal dominant 64
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06007">
   Intellectual developmental disorder with paroxysmal dyskinesia or seizures
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06049">
   Joubert syndrome 37
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06012">
   Leber hereditary optic neuropathy modifier
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06006">
   Lessel-Kreienkamp syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06031">
   Leukoencephalopathy, progressive, infantile-onset, with or without deafness
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06051">
   Li-Campeau syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06042">
   Macroglobulinemia, Waldenstrom, 1
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06017">
   Mental retardation, X-linked 50
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06044">
   Microcephaly 26, primary, autosomal dominant
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06045">
   Microcephaly 27, primary, autosomal dominant
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06016">
   Mitochondrial complex I deficiency, nuclear type 36
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06014">
   Mitochondrial complex II deficiency, nuclear type 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06015">
   Mitochondrial complex II deficiency, nuclear type 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06039">
   Mitochondrial complex II deficiency, nuclear type 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06024">
   Multiple congenital anomalies-neurodevelopmental syndrome, X-linked
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06043">
   Myopathy, myofibrillar, 11
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06009">
   Nephrotic syndrome 22
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06033">
   Nephrotic syndrome 23
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06027">
   Neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06010">
   Neurodevelopmental disorder with or without early-onset generalized epilepsy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06053">
   Neurofacioskeletal syndrome with or without renal agenesis
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06035">
   Neuropathy, hereditary motor, with myopathic features
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06034">
   Oculomotor-abducens synkinesis
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06019">
   Olmsted syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06030">
   Oocyte maturation defect 10
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06020">
   Premature ovarian failure 18
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06047">
   Proteasome-associated autoinflammatory syndrome 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06029">
   Proteasome-associated autoinflammatory syndrome 5
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06048">
   Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06023">
   Spermatogenic failure, X-linked, 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06022">
   Spermatogenic failure 51
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06021">
   Spermatogenic failure 52
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06038">
   Sulfide:quinone oxidoreductase deficiency
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06041">
   Vertebral, cardiac, tracheoesophageal, renal, and limb defects
  </a>
 </li>
</ul>
<p>
 Modified diseases:
</p>
<ul>
 <li>
  Amyotrophic lateral sclerosis 12 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02705">
   Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia
  </a>
 </li>
 <li>
  Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03119">
   Frontotemporal dementia and/or amyotrophic lateral sclerosis 6
  </a>
 </li>
 <li>
  Birk-Barel mental retardation dysmorphism syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02513">
   Birk-Barel syndrome
  </a>
 </li>
 <li>
  COACH syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02835">
   COACH syndrome 1
  </a>
 </li>
 <li>
  Diabetes mellitus, permanent neonatal 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02152">
   Diabetes mellitus, permanent neonatal, 1
  </a>
 </li>
 <li>
  Diabetes mellitus, permanent neonatal 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05823">
   Diabetes mellitus, permanent neonatal, 2
  </a>
 </li>
 <li>
  Diabetes mellitus, permanent neonatal 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05824">
   Diabetes mellitus, permanent neonatal, 3
  </a>
 </li>
 <li>
  Diabetes mellitus, permanent neonatal 4 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05825">
   Diabetes mellitus, permanent neonatal, 4
  </a>
 </li>
 <li>
  Epileptic encephalopathy, early infantile, 57 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05145">
   Developmental and epileptic encephalopathy 57
  </a>
 </li>
 <li>
  Epileptic encephalopathy, early infantile, 85, with or without midline brain defects -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05802">
   Developmental and epileptic encephalopathy 85 with or without midline brain defects
  </a>
 </li>
 <li>
  Frontotemporal dementia, chromosome 3-linked -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01633">
   Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
  </a>
 </li>
 <li>
  Generalized thyroid hormone resistance -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01654">
   Thyroid hormone resistance, generalized, autosomal dominant
  </a>
 </li>
 <li>
  Generalized thyroid hormone resistance autosomal recessive -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03097">
   Thyroid hormone resistance, generalized, autosomal recessive
  </a>
 </li>
 <li>
  Hemophagocytic lymphohistiocytosis, familial, 6 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05904">
   Immune dysregulation and systemic hyperinflammation syndrome
  </a>
 </li>
 <li>
  Intellectual developmental disorder 59 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05622">
   Intellectual developmental disorder, autosomal dominant 59
  </a>
 </li>
 <li>
  Intellectual developmental disorder 60 with seizures -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05662">
   Intellectual developmental disorder, autosomal dominant 60, with seizures
  </a>
 </li>
 <li>
  Intellectual developmental disorder 61 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05748">
   Intellectual developmental disorder, autosomal dominant 61
  </a>
 </li>
 <li>
  Intellectual developmental disorder 62 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05770">
   Intellectual developmental disorder, autosomal dominant 62
  </a>
 </li>
 <li>
  Mental retardation, autosomal recessive 15 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03241">
   Rafiq syndrome
  </a>
 </li>
 <li>
  Methylmalonic aciduria type mut -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00749">
   Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
  </a>
 </li>
 <li>
  Mitochondrial complex II deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01380">
   Mitochondrial complex II deficiency, nuclear type 1
  </a>
 </li>
 <li>
  Neurodevelopmental disorder with alopecia and brain abnormalities -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05945">
   Bachmann-Bupp syndrome
  </a>
 </li>
 <li>
  Vasculopathy, retinal, with cerebral leukodystrophy -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00261">
   Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations
  </a>
 </li>
</ul>
<p>
 Deleted disease
</p>
<ul>
 <li>
  Amyotrophic lateral sclerosis 17
 </li>
</ul>
<h3 id="Changes_to_the__a_href___docs_ptmlist__controlled_vocabulary_for_PTMs__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/ptmlist">
  controlled vocabulary for PTMs
 </a>
</h3>
<p>
 New term for the feature key 'Glycosylation' ('CARBOHYD' in the flat file):
</p>
<ul>
 <li>
  N-alpha-linked (Rha) arginine
 </li>
</ul>
<p>
 Modified term for the feature key 'Glycosylation' ('CARBOHYD' in the flat file):
</p>
<ul>
 <li>
  N-linked (GlcNAc) arginine -&gt; N-beta-linked (GlcNAc) arginine
 </li>
</ul>
<h3 id="Changes_in__a_href___docs_subcell__subcellular_location_controlled_vocabulary__a_">
 Changes in
 <a href="http://www.uniprot.org/docs/subcell">
  subcellular location controlled vocabulary
 </a>
</h3>
<p>
 New subcellular locations:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0544">
   Bacterial microcompartment
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0543">
   Cytolytic granule
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0546">
   Cytolytic granule lumen
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0547">
   Cytolytic granule membrane
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0545">
   Zymogen granule
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0548">
   Zymogen granule lumen
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0549">
   Zymogen granule membrane
  </a>
 </li>
</ul>
<h3 id="Changes_to__a_href___docs_keywlist__keywords__a_">
 Changes to
 <a href="http://www.uniprot.org/docs/keywlist">
  keywords
 </a>
</h3>
<p>
 New keyword:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1283">
   Bacterial microcompartment
  </a>
 </li>
</ul>